Evidence map›Paper›PMID 25340556›Full record

ReviewToxins2014

Bt toxin modification for enhanced efficacy.

Benjamin R Deist, Michael A Rausch, Maria Teresa Fernandez-Luna, Michael J Adang, Bryony C Bonning

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Genetic Modification Approaches for ParasporinsMolecules (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Combination Analysis BetweenFrontiers in microbiology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Benjamin R DeistDepartment of Entomology, Iowa State University, Ames, IA 50011, USA. bdeist@iastate.edu.
Michael A RauschDepartment of Entomology, Iowa State University, Ames, IA 50011, USA. mrausch@iastate.edu.
Maria Teresa Fernandez-LunaDepartment of Entomology, Iowa State University, Ames, IA 50011, USA.
Michael J AdangDepartments of Entomology, University of Georgia, Athens, GA 30602, USA. adang@uga.edu.
Bryony C BonningDepartment of Entomology, Iowa State University, Ames, IA 50011, USA. bbonning@iastate.edu.
Iowa State University · USUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insect-specific toxins derived from Bacillus thuringiensis (Bt) provide a valuable resource for pest suppression. Here we review the different strategies that have been employed to enhance toxicity against specific target species including those that have evolved resistance to Bt, or to modify the host range of Bt crystal (Cry) and cytolytic (Cyt) toxins. These strategies include toxin truncation, modification of protease cleavage sites, domain swapping, site-directed mutagenesis, peptide addition, and phage display screens for mutated toxins with enhanced activity. Toxin optimization provides a useful approach to extend the utility of these proteins for suppression of pests that exhibit low susceptibility to native Bt toxins, and to overcome field resistance.

Indexed as

AnimalsBacillus thuringiensisBacillus thuringiensis ToxinsBacterial ProteinsBiological Control AgentsEndotoxinsHemolysin ProteinsInsectaMutagenesis, Site-DirectedPest Control, BiologicalProtein ConformationBacillus thuringiensis ToxinsBacterial ProteinsBiological Control AgentsEndotoxinsHemolysin Proteinsinsecticidal crystal protein, Bacillus Thuringiensis

Identifiers

PMID25340556
PMCPMC4210883
OpenAlexW2131649352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.